Fas mutant mice are well recognized as autoimmune mouse models, which develop symptoms similar to human systemic lupus erythematosus. Although disease severity in Fas mutant mice is greatly affected by the genetic background, the mechanisms affecting pathological heterogeneity among different strains of Fas mutant mice are poorly understood. In this study, we examined the phenotypic differences between Fas-deficient (Fas 
Introduction
The cell surface death receptor, Fas (CD95), is essential for maintaining immune homeostasis and preventing autoimmunity by triggering cellular apoptosis. Studies using spontaneously mutant mouse strains carrying a homozygous defect in ) have shown that loss of the Fas-FasL system causes age-dependent onset of systemic lupus erythematosus (SLE)-like autoimmune diseases characterized by lymphadenopathy and splenomegaly accompanied by lymphoproliferation and auto-antibody production (1, 2) . It is well recognized that the genetic backgrounds of mutant mouse strains greatly affect their pathology (3) (4) (5) (6) . For instance, the original established Fas lpr/lpr mice on an MRL background (MRL-Fas lpr/lpr ) developed a more severe phenotype compared with those on C57BL/6, BALB/c, C3H or AKR backgrounds (3, 4) . Although the MRL strain is an autoimmune-prone strain, mice with the Fas lpr/lpr mutation on other genetic backgrounds also show lymphoproliferation and auto-antibody production in varying degrees (5, 6) . These studies with Fas lpr/lpr mice in a variety of backgrounds have revealed that a single Fas gene mutation is sufficient for inducing lymphoproliferation and auto-antibody production, but the magnitude and resulting gross phenotype, such as life span or renal disease, is largely dependent on the genetic background (3) (4) (5) (6) .
Pathogenic T h 2-type Tfh cells in BALB/c-Fas −/− mice
More recently, genetically engineered Fas-null (Fas −/− ) mice on a 129/C57BL/6 congenic background developed a more severe autoimmune phenotype compared with MRL-Fas lpr/lpr mice, probably due to the complete loss of the Fas molecule in Fas −/− mice, whereas the lpr mutation is a 'leaky' mutation caused by the insertion of an early transposon into the Fas locus (7, 8) . We previously generated Fas −/− mice on the BALB/c (BALB/c-Fas −/− ) (9) and C57BL/6 (C57BL/6-Fas −/− ) backgrounds (10) . BALB/c-Fas −/− mice developed a more severe autoimmune phenotype compared with MRL-Fas lpr/ lpr mice (9) . Furthermore, BALB/c-Fas −/− mice manifest a significant increase in serum IgG1 and IgE levels, and allergylike symptoms characterized by infiltration of eosinophils and neutrophils into the dermal tissue in eyelids (9, 11) . Since the allergy-like symptoms have not been reported in other Fas mutant strains, it is a unique pathological phenotype in the BALB/c background mice. These previous studies indicate that the genetic background of autoimmune-prone mice can influence the magnitude of pathology and the qualitative outcomes.
Human FAS-or FAS-related molecule-deficient syndrome is known as autoimmune lymphoproliferative syndrome (ALPS). ALPS patients manifest autoimmune symptoms closely resembling those in Fas lpr/lpr or Fasl gld/gld mice (12) . However, as with other autoimmune diseases, wide clinical heterogeneity is observed among ALPS patients (12) . In addition to the type of mutation in the same gene or differences in hetero-and homo-zygous genotypes, multiple genetic factors must be involved in the ALPS pathology, as most autoimmune syndromes are recognized as multifactorial diseases (12, 13) . Importantly, some ALPS patients manifest eosinophilia and high serum IgE levels (14) , analogous to the phenotype observed in BALB/c-Fas −/− mice (9) . Although recent genome-wide association studies revealed several susceptibility genes and loci for autoimmune diseases, the complex relationship of genetic factors and disease pathology has not been fully elucidated. Therefore, further studies on the genetic factors affecting autoimmune syndromes are essential for both a thorough understanding of the etiology and pathology of human autoimmunity, and establishing effective therapies.
A precise comparison of Fas −/− mice with different genetic backgrounds will provide important information regarding the etiological and pathological heterogeneity of autoimmune diseases. The aim of this study was to investigate the disease exacerbation factors in Fas −/− mice. We used two different backgrounds of Fas −/− mice (BALB/c-and C57BL/6-Fas −/− ) and examined differences in their phenotype to gain insight into factors affecting autoimmune disease.
Methods

Mice
Wild-type BALB/c and C57BL/6 mice were purchased from Charles River Laboratories Japan, Inc. (Yokohama, Japan). Fas −/− mice on the BALB/c and the C57BL/6 backgrounds were generated by back-crossing Fas −/− mice (7) to the respective wild-type strains for over seven generations (9, 10) . Mice were maintained under specific pathogen-free conditions, where they received sterilized food and water ad libitum. All experiments were performed in accordance with the guidelines of the Institutional Animal Care Committee of Hyogo College of Medicine.
Antibodies and reagents
mAbs used in this study were specific for mouse B220 (RA3-6B2), CD3ε (145-2C11), CD4 (RM4-5), CD28 (37.51), CD44 (IM7), CD62L (MEL-14), CD138 (281-2), CD278 (RMP1-30), CXCR5 (2G8), GL-7 (GL-7), IgD (11-26C), IgG1 (M1-14D12) and IgM (R6-60.2). These antibodies were purchased from eBioscience (San Diego, CA, USA), Biolegend (San Diego, CA, USA) or BD Biosciences (San Jose, CA, USA). Peanut Agglutinin (PNA) Rhodamine conjugate was purchased from Vector Laboratories (Burlingame, CA, USA).
Flow cytometry
Cell suspensions of spleen were prepared by sieving and gentle pipetting. For surface staining, cells were maintained in the dark at 4°C. Cells were washed in ice-cold staining buffer (1% BSA in PBS), then incubated with each antibody for 15 min and washed twice with staining buffer. Data were acquired on a FACSCanto II flow cytometer (BD Biosciences) and analyzed using FlowJo software (version 7.6.1; Tree Star, Inc., Ashland, OR, USA).
Detection of serum immunoglobulins
Mouse serum IgM, IgG1, IgG2a, IgG2b, IgG2c, IgA and IgE levels were measured by ELISA using polyvalent goat anti-mouse IgM, IgG1, IgG2a, IgG2b, IgG2c or IgA antibodies, or rat anti-mouse IgE mAb (23G3) (SouthernBiotech, Birmingham, AL, USA) as capture antibodies and biotin-conjugated polyvalent goat anti-mouse IgG1, IgG2b or IgG2c antibodies (SouthernBiotech) or biotin-conjugated rat anti-mouse IgM (R6-60.2), IgG2a (R1G-15), IgA (C10-1) or IgE (R35-118) mAbs (BD Biosciences) to the relevant specific isotypes as secondary antibodies. The serum auto-antibody levels were determined by ELISA kits for antinuclear antibodies (ANAs) and anti-Ro/SSA antibodies (Diagnostic Automation, Inc., Calabasas, CA, USA) following the manufacturer's instructions. The differential isotypes of ANAs were determined by using antigen-coated plate from ELISA kits for ANAs and secondary antibodies for each isotype of immunoglobulins.
Histological examination
Tissues were fixed in 4% (w/v) paraformaldehyde, embedded in paraffin, sectioned at 4 μm and stained with hematoxylin and eosin (HE) or Periodic acid-Schiff (PAS) stain. For IgG1 and C3 staining, frozen sections of freshly isolated kidney specimens were incubated with FITC-conjugated anti-IgG1 mAb or FITC-conjugated goat anti-mouse C3 antibody (Immunology Consultants Laboratory, Inc., Portland, OR, USA). For germinal center (GC) staining, frozen sections of freshly isolated spleen specimens were incubated with allophycocyanin (APC)-conjugated anti-IgD mAb and PNA rhodamine conjugate, and then mounted with Prolong Antifade Gold with DAPI (Invitrogen, San Diego, CA, USA). ), streptomycin (100 μg ml -1 ), l-glutamine (2 mM) and β-mercaptoethanol (50 μM). Supernatants were collected, and cytokine production was assessed by using the Bio-Plex™ System (Bio-Rad Laboratories, Inc., Tokyo, Japan).
In vitro follicular helper T-cell stimulation
Detection of cytokines by cytokine multiplex assay
Bio-Plex™ Pro mouse cytokine multiplex assay kits and the Bio-Plex™ 200 System with high-throughput fluidic (Bio-Rad Laboratories, Inc.) were used following the manufacturer's instructions.
Reverse transcription-PCR
Total RNAs from splenic Tfh cells or B cells were prepared using RNeasy MiniKits (Qiagen, Venlo, Netherlands) and cDNA was synthesized using ReverTra Ace (Toyobo, Osaka, Japan). The expression of genes was quantified with TaqMan Gene Expression Assays (Applied Biosystems) and the Thermal cycler dice RT-PCR system (Takara Bio, Inc., Otsu, Japan) according to the manufacturer's instructions. The results were shown as the relative expression standardized with the expression of a gene encoding eukaryotic 18S ribosomal RNA (rRNA). The specific primers and probes used for quantitative reverse transcription-PCR were TaqMan probes for Il4, IL10, Il13, Il17, Il21, Ifng, Aicda, Bcl6, Prdm1 and 18S rRNA (Applied Biosystems).
Statistical analysis
Statistical significance was determined by Bonferroni's multiple comparison test or two-tailed Student's t-test. P values <0.05 were considered statistically significant. All experiments were performed two or three times and representative results are shown.
Results
Hyperimmunoglobulinemia in BALB/c-Fas −/− mice
We previously reported that BALB/c-Fas −/− mice show higher serum IgG1, IgE and auto-antibody levels (ANAs and antiRo/SSA antibodies) compared with MRL-Fas lpr/lpr mice (9, 11). However, the lpr mutation does not result in the complete loss of Fas, making it difficult to conclude that the BALB/c background causes higher auto-antibody titers. To determine the impact of Fas null mutation in different backgrounds, we used two immunologically well-characterized mouse strains, BALB/c and C57BL/6 mice, as genetic backgrounds for Fas −/− mice. All immunoglobulins tested were elevated in BALB/cFas −/− mice compared with wild-type BALB/c mice. Especially, IgG1, IgG2a, IgA and IgE levels were significantly higher in BALB/c-Fas −/− mice (Fig. 1A ). Only IgG2c levels, which are the C57BL/6 counterpart of IgG2a in the BALB/c strain, were significantly higher in C57BL/6-Fas −/− mice compared with wild-type C57BL/6 mice. However, other immunoglobulin isotypes were comparable between C57BL/6-Fas −/− mice and wild-type C57BL/6 mice (Fig. 1A) . As we showed previously (9), BALB/c-Fas −/− mice developed high serum ANAs and anti-Ro/SSA antibodies, whereas negligible levels of serum auto-antibodies were detected in C57BL/6-Fas −/− mice (Fig. 1B) . Furthermore, we examined the isotypes of ANAs in the sera. As expected, high levels of IgM, IgG1 and IgG2a ANAs were detected in BALB/c-Fas −/− mice (Supplementary Figure S1 , available at International Immunology Online). These results demonstrated that self-reactive B cells were highly activated and received signals for class switch recombination in BALB/c-Fas −/− mice. BALB/c-Fas −/− mice showed age-dependent auto-antibody production similar to other Fas mutant mouse strains, which was maximal at ~20 weeks of age (Fig. 1B) . Thus, we used mice at around 20 weeks old (18-23 weeks old) for the later studies.
Serological examinations indicated that Fas −/− mice on the BALB/c background showed a more severe autoimmune phenotype compared with C57BL/6 background mice in terms of hyperimmunoglobulinemia.
Glomerulonephritis-like symptoms in BALB/c-Fas
−/− mice A characteristic pathology induced by high serum auto-antibody levels is immune complex-mediated renal disease (15) . Although auto-antibody production is observed in almost all mouse strains carrying homozygous Fas mutations, pathological features in the kidney differ greatly among them (5, 6) . Thus, we examined the histopathology and immunohistochemistry of kidneys from BALB/c-and C57BL/6-Fas −/− mice. Serum IgG1 antibody levels were high in BALB/c-Fas −/− mice ( Fig. 1A) and intense glomerular IgG1 deposition was detected in the kidneys. Although IgG1 deposition was also detected in C57BL/6-Fas −/− mice, but not in wild-type mice, the magnitude was much lower than in BALB/c-Fas −/− mice ( Fig. 2A) . Since levels of complement-fixing antibodies such as IgG2a were high in BALB/c-Fas −/− mice (Fig. 1A) , we also examined the deposition of complement component C3, which is an important and a characteristic feature of immune complex-mediated renal diseases (15) . Again, BALB/c-Fas −/− mice showed the highest glomerular C3 deposition in the kidneys among the mice investigated (Fig. 2B) . In addition, histological examination of the kidneys revealed that PAS-positive matrix was abundant and the epithelia of Bowman's capsule formed a cylindrical structure in the glomeruli in BALB/c-Fas −/− mice. In contrast, little change was observed in the glomeruli of C57BL/6-Fas −/− mice compared with wild-type mice (Fig. 2C ). In addition, urinary protein excretion was higher in BALB/c-Fas −/− mice compared with C57BL/6-Fas −/− mice (data not shown). These results clearly −/− mice indicate that BALB/c-Fas −/− but not C57BL/6-Fas −/− mice suffer from immune complex-mediated renal disease histologically resembling glomerulonephritis.
In contrast to auto-antibody production and renal disease, both BALB/c-Fas −/− and C57BL/6-Fas −/− mice showed considerable accumulation of unusual CD3 (Fig. 3B) . The GC is an important immunological site for B cells to undergo immunoglobulin class switching and antibody affinity maturation (16) . Thus, we investigated the difference in GC formation in the spleens of the Fas −/− mice. FACS analysis revealed that ~5% of B cells in BALB/cFas −/− mice were PNA + and GL-7+ GC B cells, whereas GC B cells were almost undetectable in wild-type controls (Fig. 3C) . Immunohistochemical examination of spleens from BALB/cFas −/− mice showed the presence of PNA + cells inside the B-cell follicle, clearly indicating GC formation (Fig. 3D) . In contrast, PNA + GL-7 + GC B cells were comparable between C57BL/6-Fas −/− mice and wild-type controls and little or no GC formation was detectable in C57BL/6-Fas −/− mouse spleens ( Fig. 3C and D) . Again, B-cell hyperactivation was evident in BALB/c-Fas
, but not in C57BL/6-Fas −/− mice. Next, we examined mRNA expression in splenic B cells. Compared with wild-type B cells, BALB/c-Fas −/− B cells expressed >35-fold higher levels of mRNA for activationinduced cytidine deaminase (AID), encoded by Aicda, which is essential for induction of B-cell class switching and antibody affinity maturation (17) (Fig. 4) . In C57BL/6-Fas −/− mice, Aicda expression in B cells was comparable to wild-type cells. The expression of Blimp-1, encoded by Prdm1, which is required for B cells to differentiate into plasma cells (18), 
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−/− mice was also up-regulated in BALB/c-Fas −/− mice. B cells from C57BL/6-Fas −/− mice expressed comparably high levels of Prdm1, even though this was not statistically significant when compared with wild-type controls (Fig. 4) . A transcriptional repressor in B cells, Bcl-6 (18), encoded by Bcl6, was not augmented in Fas −/− B cells of both strains (Fig. 4) . These results clearly indicated that B cells were highly activated, and GC formation and immunoglobulin class switching were enhanced in BALB/c-Fas −/− mice, to which the hyperimmunoglobulinemia was attributable.
Comparable frequency of Tfh cells between BALB/c-and C57BL/6-Fas
−/− mice Tfh cells are a distinct subset of CD4 + helper T cells that regulate the development of antigen-specific humoral immunity by providing essential help for B cells in GCs and play a critical role in the development of autoimmune diseases (16) . Since BALB/c-Fas −/− mouse B cells showed enhanced activation and class switching in GCs, we next investigated the splenic Tfh cell population. As previously reported, in lpr mutant strains, CD44 high CD62L low effector/memory CD4 + T cells were abundant in both strains of Fas −/− mice at comparable levels (Fig. 5A) (Fig. 5B) . Thus, the expansion of Tfh cell differentiation alone does not explain the augmented B-cell activation in BALB/c-Fas −/− mice. (16) , and Bcl6, a characteristic and essential transcription factor for Tfh cell development (16) . Of note, Tfh cells from both genetic backgrounds expressed higher levels of 
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frequency of Tfh cells, they are qualitatively different, and that BALB/c-Fas −/− mouse-derived Tfh cells produce higher amounts of B-cell-activating cytokines. We propose that IL-4 and IL-10 are the candidate cytokines that may contribute to enhanced B-cell activation and high immunoglobulin production in BALB/c-Fas −/− mice. Furthermore, the phenotype of Tfh cells in BALB/c-Fas −/− mice is reminiscent of T h 2-type Tfh cells described in human studies (18) .
Discussion
In this study, we examined the phenotypic differences of Fas −/− mice with BALB/c and C57BL/6 genetic backgrounds. BALB/c-Fas −/− mice developed more severe autoimmune symptoms including hyperimmunoglobulinemia and renal disease, whereas no difference was observed in tissue lymphoinfiltration between these strains. Splenic B cells in BALB/c-Fas −/− mice were strongly activated, expressed high levels of AID and differentiated into class-switched memory B cells. The GC is an essential immunological site for B-cell class switching and antibody affinity maturation, and BALB/cFas −/− mice developed GC formation in the spleen. In contrast, C57BL/6-Fas −/− mice showed negligible auto-antibody production and B-cell activation. These results indicated that antibody production-mediated symptoms observed in Fas −/− mice were highly exacerbated in mice with a BALB/c background. It is well recognized that the disease phenotype of Fas mutant mice is greatly affected by the genetic background. Auto-antibody production and renal disease in Fas lpr/lpr mice with MRL, C57BL/6, BALB/c, C3H or AKR backgrounds have been investigated (1-6). However, the mechanisms involved in the differences have not been fully investigated. In this study, we examined the potential cause of pathological heterogeneity of Fas −/− mice on different genetic backgrounds. We showed that Tfh cells from BALB/c-Fas (23) . Even though B-cell-specific Fas-deficient mice develop autoimmunity and have early mortality, the removal of T cells or deletion of CD28 in these mice totally restores the phenotype including B-cell activation (23) . In addition, deletion of inducible costimulator (ICOS), which is highly expressed on Tfh cells and plays a critical role in GC B-cell activation (16) , in MRLFas lpr/lpr mice significantly reduced auto-antibody production (25, 26) . These studies suggest that although activated B cells play an essential role in initiating disease, interactions between B and T cells, especially Tfh cells in GCs, are important for the progression of antibody production and the pathology. Indeed, we previously showed that splenic B cells from BALB/c-Fas −/− and wild-type mice produced comparable levels of IgG1 and IgE in response to IL-4 and anti-CD40 antibody stimulation in vitro (11) . This indicates that B-cellintrinsic abnormalities alone cannot explain the hyperimmunoglobulinemia observed in BALB/c-Fas −/− mice. Among the cytokines produced by Tfh cells, IL-21 is characteristic and important for GC B-cell survival and differentiation (16, 27) . However, even though Il21r −/− mice show some humoral immunity defects, they are still capable of developing GC responses (28) . Thus, other Tfh cell cytokines must be essential for activating GC B cells. IL-4 may be one of these cytokines, since IL-4 and IL-21R double-deficient mice show pan-hypogammaglobulinemia indicating cooperative roles of the two cytokines (29) . IL-4 is well recognized as an indispensable cytokine for B-cell class switching to IgG1 and IgE, of which BALB/c-Fas −/− mice produce large amounts. In addition, accumulating evidence suggests that IL-4 produced by Tfh cells, rather than by T h 2 cells, is important for controlling humoral immunity (16, (30) (31) (32) . IL-10 is another Tfh cytokine (33) , which can enhance B-cell antibody production (18) . Although IL-10 is considered an anti-inflammatory cytokine that is essential for preventing autoimmunity, IL-10 also has a B-cell-activating capacity (21, 22) and some reports have demonstrated a pathological role for IL-10 in auto-antibody production (34, 35) . Thus, IL-10 could also be a predisposing factor for autoimmunity in some disease settings. Taken together, we propose that IL-4 and IL-10 produced by Tfh cells are the likely causes of high GC formation and the severe autoimmune phenotype in BALB/c-Fas −/− mice. Tfh cells are considered a heterogenic population, which can be further divided into several cell types depending on their cytokine, chemokine or chemokine receptor profiles. Although Tfh cells can produce the T h 1 cytokine IFN-γ (36), T h 2 cytokine IL-4 (19, 20, 30) , or T h 17 cytokine IL-17 (37) in certain conditions, the presence of specialized T h 1-, T h 2-or T h 17-type Tfh cells is still controversial (16) . However, Morita et al. (18) clearly showed that circulating human Tfh cells can be classified into the three subtypes, T h 1, T h 2 or T h 17 type depending on their unique cytokine and chemokine receptor profiles characteristic for conventional T h 1, T h 2 and T h 17 cells, and which differentially help B-cell antibody production. The high IL-4, as well as IL-13, production of Tfh cells from BALB/c-Fas −/− mice suggests they are similar to human T h 2-type Tfh cells. This similarity is also seen in their B-cell-helping capacity. BALB/c-Fas −/− mice showed high IgG1, IgG2a and IgE levels in the sera, and human T h 2-type Tfh cells preferentially help B cells to produce IgG and IgE antibodies (18) . Interestingly, Morita et al. (18) also showed that T h 2-and T h 17-type Tfh cells are more pathogenic than the T h 1 type, and skewing of Tfh cells toward T h 2 and T h 17 types correlates with disease activity in an autoimmune disease, juvenile dermatomyositis. Furthermore, T h 2-type Tfh cells have been reported in mice, where IL-4-producing Tfh cells contribute to immunity against helminthic infection by promoting IgE production (19, 20, 30) . These reports support our hypothesis that the pathological heterogeneity of the autoimmune phenotype between BALB/c-Fas −/− and C57BL/6-Fas −/− mice is ascribed to their different Tfh cell populations. The accumulation of T h 2-type Tfh cells also explains the unique allergy-like phenotype of BALB/c-Fas −/− mice. We recently identified a novel innate cell population, Fas-expressing natural helper (F-NH) cells, which are abundant in BALB/c-Fas −/− mice and enhance B-cell IgG1 and IgE production in the presence of IL-4 (11). F-NH cells may also enhance IgG1 and IgE production in vivo, although the source of IL-4 was unclear (11) . The IL-4-producing Tfh cells and F-NH cells may cooperate to augment serum IgG1 and IgE levels and exacerbate the allergy-like phenotype, which is uniquely observed in BALB/c-Fas −/− mice (9). The human FAS or FAS-related molecule deficiency, ALPS, is characterized by lymphadenopathy, splenomegaly and hypergammaglobulinemia, which are also observed in Fas mutant mice (12, 13) . Similar to Fas mutant mouse models, disease severity differs among patients and, more importantly, some, but not all, ALPS patients manifest eosinophilia and increased serum IgE levels (14) . ALPS patients with eosinophilia show a higher mortality rate than those without eosinophilia (14) . Although the etiology of eosinophilic ALPS is unexplained, our results may aid our understanding. Disease heterogeneity might be explained by the accumulation of 'pathogenic' Tfh cells. In addition to ALPS, several human diseases, especially auto-antibody-mediated diseases, such as SLE or rheumatoid arthritis, can be caused by the dysregulation of Tfh cells (38) . It was reported that serum concentrations of IgE and anti-dsDNA antibodies were associated with disease severity in SLE patients (39, 40) . Our results may also provide an important bridge between Tfh phenotype and disease heterogeneity among patients suffering from auto-antibody-mediated diseases.
In addition to Fas mutant mice, several gene-targeted mice have been back-crossed onto both the BALB/c and the C57BL/6 background. In some cases, the differential genetic backgrounds have a huge impact on their phenotype. The BALB/c background is not as autoimmune prone compared with the C57BL/6 background. For instance, Ship1 −/− mice show a more severe autoimmune phenotype such as autoantibody production and glomerulonephritis on the C57BL/6 background compared with the BALB/c background (41) . In addition, C57BL/6-Fcgr2b −/− but not BALB/c-Fcgr2b −/− mice develop severe autoimmune disease (42) . The complex combination of the presence of predisposing factors and absence of protecting factors may explain disease susceptibility and exacerbation in different strains. However, as none of these studies documented direct target genes affecting the phenotype, it remains unclear which genes or loci actually influence the different phenotype between BALB/c-and C57BL/6-Fas −/− mice. Future studies using gene mapping may uncover the real target(s) of disease exacerbation or protection due to background genotype.
In summary, we showed that BALB/c-and C57BL/6-Fas 
